Organigram Global (OGI) Share-based Compensation (2018 - 2026)
Organigram Global (OGI) posted quarterly Share-based Compensation of $1.1 million for Q1 2026, up 67.1% year-over-year from $653707.7 in Q1 2025, and up 97.83% quarter-over-quarter from $552156.4 in Q4 2025.
Organigram Global (OGI) Share-based Compensation (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Share-based Compensation for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 67.1% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $3.2 million (down 46.96% YoY), while the FY2025 annual figure was $3.1 million, down 41.8% from the prior year.
- Share-based Compensation climbed to $1.1 million in Q1 2026 per OGI's latest filing, from $552156.4 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.1 million in Q1 2026 and bottomed at $552156.4 in Q4 2025.
- Historically, Share-based Compensation has averaged $811678.6 across 3 years, with a median of $801103.9 in 2024.
- Annual changes were most pronounced in 2025 — Share-based Compensation plunged 41.79% — and 2026, when it surged 67.1%.
- Organigram Global's Share-based Compensation stood at $948500.1 in 2024, then slumped by 41.79% to $552156.4 in 2025, then surged by 97.83% to $1.1 million in 2026.
- Business Quant data shows OGI's Share-based Compensation at $1.1 million in Q1 2026, $552156.4 in Q4 2025, and $653707.7 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 552,156.44 |
| Dec 31, 2025 | 552,156.44 |
| Mar 31, 2025 | 653,707.65 |
| Mar 31, 2025 | 653,707.65 |
| Dec 31, 2024 | 948,500.11 |
| Dec 31, 2024 | 948,500.11 |
| May 31, 2021 | 2.75 Mn |
| May 31, 2021 | 2.75 Mn |
| Feb 28, 2021 | 1.77 Mn |
| Feb 28, 2021 | 1.77 Mn |
| Nov 30, 2020 | 606,000.00 |
| Nov 30, 2020 | 606,000.00 |
| Aug 31, 2020 | 486,689.00 |
| Aug 31, 2020 | 486,689.00 |
| May 31, 2020 | 1.39 Mn |
| May 31, 2020 | 1.39 Mn |
| Feb 29, 2020 | 2.40 Mn |
| Feb 29, 2020 | 2.40 Mn |